HK1032012A1 - Oral liquid solution comprising the antidepressant mirtazapine - Google Patents
Oral liquid solution comprising the antidepressant mirtazapineInfo
- Publication number
- HK1032012A1 HK1032012A1 HK01102818A HK01102818A HK1032012A1 HK 1032012 A1 HK1032012 A1 HK 1032012A1 HK 01102818 A HK01102818 A HK 01102818A HK 01102818 A HK01102818 A HK 01102818A HK 1032012 A1 HK1032012 A1 HK 1032012A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oral liquid
- liquid solution
- mirtazapine
- antidepressant mirtazapine
- antidepressant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98201037 | 1998-04-02 | ||
PCT/EP1999/002277 WO1999051237A1 (en) | 1998-04-02 | 1999-03-29 | Oral liquid antidepressant solution |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1032012A1 true HK1032012A1 (en) | 2001-07-06 |
Family
ID=8233550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01102818A HK1032012A1 (en) | 1998-04-02 | 2001-04-20 | Oral liquid solution comprising the antidepressant mirtazapine |
Country Status (12)
Country | Link |
---|---|
US (2) | US6040301A (xx) |
EP (1) | EP1067934B1 (xx) |
AT (1) | ATE254918T1 (xx) |
AU (1) | AU747975B2 (xx) |
BR (1) | BR9909357A (xx) |
CA (1) | CA2326356C (xx) |
DE (1) | DE69913116T2 (xx) |
DK (1) | DK1067934T3 (xx) |
ES (1) | ES2212550T3 (xx) |
HK (1) | HK1032012A1 (xx) |
PT (1) | PT1067934E (xx) |
WO (1) | WO1999051237A1 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
WO2002064735A2 (en) * | 2001-02-12 | 2002-08-22 | Akzo Nobel N.V. | Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US20040156894A1 (en) * | 2003-02-07 | 2004-08-12 | Grother Leon Paul | Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
WO2006023703A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders |
WO2006031720A2 (en) * | 2004-09-14 | 2006-03-23 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
JP2008519055A (ja) * | 2004-11-08 | 2008-06-05 | シャイア エルエルシー | ミルタザピンと興奮剤複合物の併用投与の相乗効果 |
TW200631584A (en) * | 2004-11-15 | 2006-09-16 | Akzo Nobel Nv | A medicament related to mirtazapine for the treatment of hot flush |
WO2006055854A2 (en) * | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
WO2008157094A1 (en) * | 2007-06-13 | 2008-12-24 | Cypress Bioscience, Inc. | Improving the tolerability of mirtazapine and a second active by using them in combination |
EP2567069A4 (en) | 2010-05-05 | 2014-04-16 | Ener G Rotors Inc | FLUIDIC ENERGY TRANSMISSION DEVICE |
US8714951B2 (en) * | 2011-08-05 | 2014-05-06 | Ener-G-Rotors, Inc. | Fluid energy transfer device |
DK3261645T3 (da) | 2015-02-27 | 2021-06-07 | Dechra Ltd | Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
ATE99943T1 (de) * | 1989-12-06 | 1994-01-15 | Akzo Nv | Psychotropische wirkstoffe enthaltende stabilisierte loesungen. |
US5208261A (en) * | 1989-12-06 | 1993-05-04 | Akzo N.V. | Stabilized solutions of psychotropic agents |
IE63986B1 (en) * | 1989-12-30 | 1995-06-28 | Akzo Nv | Pharmaceutical preparation for oral administration in fluid form |
US5238699A (en) * | 1991-11-27 | 1993-08-24 | Kraft General Foods, Inc. | Ready-to-eat, low/no-fat puddings and process |
-
1999
- 1999-03-29 DE DE69913116T patent/DE69913116T2/de not_active Expired - Lifetime
- 1999-03-29 PT PT99917956T patent/PT1067934E/pt unknown
- 1999-03-29 AT AT99917956T patent/ATE254918T1/de active
- 1999-03-29 WO PCT/EP1999/002277 patent/WO1999051237A1/en active IP Right Grant
- 1999-03-29 CA CA002326356A patent/CA2326356C/en not_active Expired - Fee Related
- 1999-03-29 EP EP99917956A patent/EP1067934B1/en not_active Expired - Lifetime
- 1999-03-29 ES ES99917956T patent/ES2212550T3/es not_active Expired - Lifetime
- 1999-03-29 DK DK99917956T patent/DK1067934T3/da active
- 1999-03-29 AU AU36048/99A patent/AU747975B2/en not_active Ceased
- 1999-03-29 BR BR9909357-0A patent/BR9909357A/pt not_active Application Discontinuation
- 1999-04-01 US US09/283,945 patent/US6040301A/en not_active Expired - Fee Related
- 1999-07-22 US US09/358,772 patent/US6114324A/en not_active Expired - Fee Related
-
2001
- 2001-04-20 HK HK01102818A patent/HK1032012A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1067934A1 (en) | 2001-01-17 |
CA2326356C (en) | 2008-06-03 |
WO1999051237A1 (en) | 1999-10-14 |
DE69913116T2 (de) | 2004-06-03 |
ATE254918T1 (de) | 2003-12-15 |
BR9909357A (pt) | 2000-12-12 |
DK1067934T3 (da) | 2004-03-29 |
AU3604899A (en) | 1999-10-25 |
CA2326356A1 (en) | 1999-10-14 |
PT1067934E (pt) | 2004-03-31 |
ES2212550T3 (es) | 2004-07-16 |
US6040301A (en) | 2000-03-21 |
US6114324A (en) | 2000-09-05 |
DE69913116D1 (de) | 2004-01-08 |
EP1067934B1 (en) | 2003-11-26 |
AU747975B2 (en) | 2002-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1032012A1 (en) | Oral liquid solution comprising the antidepressant mirtazapine | |
YU84703A (sh) | Oralni rastvor aripiprazola | |
SG49049A1 (en) | 5-(-2-Imidazolinylamino) benzimidazole derivatives their preparation and their use as alpha-2 adrenoceptor agonists | |
NZ234143A (en) | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents | |
BR9917007A (pt) | Moduladores de ccr5 | |
AP2000001860A0 (en) | Hypolipidemic benzothiazepine compounds. | |
PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
LU91281I2 (fr) | Preotact-hormone parathyroïde | |
WO2000002542A3 (de) | Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum | |
MX9605741A (es) | Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano. | |
ATE249205T1 (de) | Wässrige suspension zur nasalen verabreichung von loteprednol | |
HRP20010969B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, | |
PL350917A1 (en) | C16 unsaturated fp-selective prostaglandins analogs | |
MX9805141A (es) | Uso de inhibidores del intercambiador celular na+/h+ (nhe) para la preparacion de un farmaco para estimular la respiracion. | |
ES2108595A1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
BR0104358A (pt) | Formulações de taxana tendo solubilidade aperfeiçoada | |
AU6220300A (en) | Benzofurylpiperazine serotonin agonists | |
HUP0002928A2 (hu) | D3 vitamint és trikalcium-foszfátot tartalmazó stabil szilárd készítmény, és eljárás előállítására | |
BR9812982A (pt) | Agente anti-reumático | |
MXPA03008837A (es) | Una composicion farmaceutica estable de pravastatina. | |
BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
MY139455A (en) | Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid | |
HU9600758D0 (en) | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption | |
HUP0302255A2 (hu) | Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
PT1283042E (pt) | Preparação líquida aquosa de pranoprofeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090329 |